![](/img/cover-not-exists.png)
Outcomes of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Following an Elective Switch From Second-Generation Tyrosine Kinase Inhibitor to Imatinib
Kota, Vamsi K., Kong, Jee Hyun, Arellano, Martha, El Rassi, Fuad, Gaddh, Manila, Heffner, Leonard T., Winton, Elliott F., Jillella, Anand P., McLemore, Morgan L., Khoury, H. JeanLanguage:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2017.09.004
Date:
September, 2017
File:
PDF, 203 KB
english, 2017